These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12678490)

  • 21. [Congenital muscular dystrophy and alpha-dystroglycanopathy].
    Saito F; Matsumura K; Hagiwara H; Shimizu T
    Rinsho Shinkeigaku; 2008 Aug; 48(8):543-9. PubMed ID: 18939472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of Fukutin-related protein and rescues disease phenotype in a murine model of limb-girdle muscular dystrophy type 2I.
    Frattini P; Villa C; De Santis F; Meregalli M; Belicchi M; Erratico S; Bella P; Raimondi MT; Lu Q; Torrente Y
    Hum Mol Genet; 2017 Oct; 26(19):3682-3698. PubMed ID: 28666318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.
    Barresi R; Michele DE; Kanagawa M; Harper HA; Dovico SA; Satz JS; Moore SA; Zhang W; Schachter H; Dumanski JP; Cohn RD; Nishino I; Campbell KP
    Nat Med; 2004 Jul; 10(7):696-703. PubMed ID: 15184894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage.
    Martin PT
    Nat Clin Pract Neurol; 2006 Apr; 2(4):222-30. PubMed ID: 16932553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscular dystrophies.
    Nishino I; Ozawa E
    Curr Opin Neurol; 2002 Oct; 15(5):539-44. PubMed ID: 12351997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
    Hayashi YK; Ogawa M; Tagawa K; Noguchi S; Ishihara T; Nonaka I; Arahata K
    Neurology; 2001 Jul; 57(1):115-21. PubMed ID: 11445638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
    Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
    Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies.
    Cirak S; Foley AR; Herrmann R; Willer T; Yau S; Stevens E; Torelli S; Brodd L; Kamynina A; Vondracek P; Roper H; Longman C; Korinthenberg R; Marrosu G; Nürnberg P; ; Michele DE; Plagnol V; Hurles M; Moore SA; Sewry CA; Campbell KP; Voit T; Muntoni F
    Brain; 2013 Jan; 136(Pt 1):269-81. PubMed ID: 23288328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscular dystrophies due to glycosylation defects.
    Muntoni F; Torelli S; Brockington M
    Neurotherapeutics; 2008 Oct; 5(4):627-32. PubMed ID: 19019316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
    Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
    Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I.
    Boito CA; Melacini P; Vianello A; Prandini P; Gavassini BF; Bagattin A; Siciliano G; Angelini C; Pegoraro E
    Arch Neurol; 2005 Dec; 62(12):1894-9. PubMed ID: 16344347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fukutin-related protein gene mutated in the original kindred limb-girdle MD 2I.
    Driss A; Noguchi S; Amouri R; Kefi M; Sasaki T; Sugie K; Souilem S; Hayashi YK; Shimizu N; Minoshima S; Kudoh J; Hentati F; Nishino I
    Neurology; 2003 Apr; 60(8):1341-4. PubMed ID: 12707439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse.
    Grewal PK; Holzfeind PJ; Bittner RE; Hewitt JE
    Nat Genet; 2001 Jun; 28(2):151-4. PubMed ID: 11381262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies.
    Brown SC; Torelli S; Brockington M; Yuva Y; Jimenez C; Feng L; Anderson L; Ugo I; Kroger S; Bushby K; Voit T; Sewry C; Muntoni F
    Am J Pathol; 2004 Feb; 164(2):727-37. PubMed ID: 14742276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families.
    Louhichi N; Triki C; Quijano-Roy S; Richard P; Makri S; Méziou M; Estournet B; Mrad S; Romero NB; Ayadi H; Guicheney P; Fakhfakh F
    Neurogenetics; 2004 Feb; 5(1):27-34. PubMed ID: 14652796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathomechanism and therapeutic strategy of Fukuyama congenital muscular dystrophy and related disorders].
    Toda T
    Rinsho Shinkeigaku; 2009 Nov; 49(11):859-62. PubMed ID: 20030231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].
    Murakami T; Nishino I
    Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
    Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
    Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective glycosylation in congenital muscular dystrophies.
    Muntoni F; Brockington M; Torelli S; Brown SC
    Curr Opin Neurol; 2004 Apr; 17(2):205-9. PubMed ID: 15021250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy.
    Larson AA; Baker PR; Milev MP; Press CA; Sokol RJ; Cox MO; Lekostaj JK; Stence AA; Bossler AD; Mueller JM; Prematilake K; Tadjo TF; Williams CA; Sacher M; Moore SA
    Skelet Muscle; 2018 May; 8(1):17. PubMed ID: 29855340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.